InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Browse the detailed record of transactions filed by Kerr Douglas, Chief Medical Officer. Officer active across 2 companies, notably Dyne Therapeutics, Inc.. Aggregated, 4 disclosures have been logged. Total volume traded: €49k. The latest transaction was filed on 13 May 2026 — Cession. Regulator: SEC (Form 4). All data is openly available.
Declarations4 total
€24,5091,564 shares@ €15.67080.0009% mcap50.0% of flow
Common Stock
SEC:0001193125-26-223966:0·
US$24,5091,564 shares@ US$15.67080.0009% mcap100.0% of flow
Common Stock
SEC:0001193125-26-223966·
€15,3213,518 shares@ €4.3552100.0% of flow
Common Stock
SEC:0001415889-21-003583·
€15,3213,518 shares@ €4.355250.0% of flow
Common Stock
SEC:0001415889-21-003583:0·
4 of 4 declarations
About Kerr Douglas
Douglas Kerr is the Chief Medical Officer at Dyne Therapeutics, Inc. and Generation Bio Co. He is responsible for medical strategy and overseeing clinical programs. His expertise is crucial for the development of innovative treatments.
